Audiology and Otosurgery Unit, Department of Surgery, Cochlear Implant Referral Center, "Bambino Gesù" Pediatric Hospital, Piazza Sant'Onofrio, 4, 00165, Rome, Italy.
Oncohematology Department, Haemostasis and Thrombosis Center, Bambino Gesù Pediatric Hospital, Rome, Italy.
Eur Arch Otorhinolaryngol. 2018 Aug;275(8):1971-1977. doi: 10.1007/s00405-018-5033-1. Epub 2018 Jun 8.
To describe the prevalent clinical, laboratory, and radiological features of otogenic lateral sinus thrombosis (OLST) in children; to identify clinical predictors of outcome; to propose a management algorithm derived from experience.
A retrospective review was conducted of the clinical records of patients with OLST, treated in a single tertiary care referral center for pediatric disease from 2006 to 2017. The inclusion criteria were pediatric age (0-16 years) and OLST diagnosis confirmed by a pre- and post-contrast CT or venography-MRI scan. Primary outcome measures were early (1-2 months) and late (6 months) sinus recanalization assessed by means of neuroimaging.
Twenty-five patients (8 females and 17 males; mean age = 6 ± 3 years) were included. A genetic abnormality associated with thrombophilia was found in 24 (96%) patients. At diagnosis, anticoagulant treatment with low-molecular-weight heparin (LMWH) was started in all subjects, while surgical treatment (mastoidectomy and tympanostomy tube insertion) was performed in 16/25 (64%) patients. Follow-up neuroimaging showed lateral sinus recanalization in 12/25 (48%) patients after 1-2 months and in 17/25 (68%) after 6 months. At multivariate logistic regression analysis, no significant predictors of the early and late neuroradiological outcome were found.
All children with OLST should be screened for thrombophilia to decide on treatment duration and to assess the need for future antithrombotic prophylaxis. Immediately after diagnosis, anticoagulant treatment with LMWH should be started according to the international guidelines. Instead, our experience suggests that surgical treatment should not be indicated in all patients, but decided on a case-to-case basis.
描述儿童源性外侧窦血栓形成(OLST)的常见临床、实验室和影像学特征;确定结局的临床预测因素;提出一种源自经验的管理算法。
对 2006 年至 2017 年期间在一家专门的儿科疾病三级转诊中心接受治疗的 OLST 患儿的临床记录进行了回顾性分析。纳入标准为儿科年龄(0-16 岁)和经对比前、后 CT 或静脉造影 MRI 扫描证实的 OLST 诊断。主要转归指标为神经影像学评估的早期(1-2 个月)和晚期(6 个月)窦再通。
共纳入 25 例患者(8 例女性和 17 例男性;平均年龄 6±3 岁)。24 例(96%)患者发现与血栓形成倾向相关的遗传异常。在诊断时,所有患者均开始接受低分子肝素(LMWH)抗凝治疗,而 16/25(64%)例患者进行了手术治疗(乳突切除术和鼓膜造口术置管)。1-2 个月后,25 例患者中有 12 例(48%),6 个月后有 17 例(68%)的外侧窦再通。多变量逻辑回归分析显示,早期和晚期神经影像学结局无显著预测因素。
所有 OLST 患儿均应筛查血栓形成倾向,以确定治疗持续时间并评估未来抗血栓预防的需要。应根据国际指南立即开始 LMWH 抗凝治疗。相反,我们的经验表明,并非所有患者均需进行手术治疗,而是应根据具体情况决定。